| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/28/1992 | CA1295087C Purification of recombinant beta-interferon incorporating rp-hplc |
| 01/28/1992 | CA1294901C Monoclonal antibody specific for human colon fibroblast-derived t-pa |
| 01/28/1992 | CA1294900C Gentamicin-resistance genes and their use as markers |
| 01/28/1992 | CA1294899C Carbonic anhydrase inhibitor-tagged nucleic acid probes |
| 01/28/1992 | CA1294879C Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone dna, and a method for administering bgh in vivo |
| 01/28/1992 | CA1294873C Method of regulating animal reproduction |
| 01/27/1992 | WO1992001786A1 Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes |
| 01/27/1992 | CA2088154A1 Portable ribozyme cassettes, dna sequences containing them, ribozyme encoded by these dna sequences, and compositions containing these ribozymes |
| 01/27/1992 | CA2047837A1 Bifunctional cosmid useful for cloning actinomycete dna |
| 01/27/1992 | CA2046699A1 Continuous bacterial mutation process |
| 01/26/1992 | WO1992001813A1 Circular extension for generating multiple nucleic acid complements |
| 01/26/1992 | WO1992001787A1 Binding domains |
| 01/26/1992 | CA2087256A1 Circular extension for generating multiple nucleic acid complements |
| 01/26/1992 | CA2087095A1 Binding domains |
| 01/26/1992 | CA2047769A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/25/1992 | WO1992001792A1 Recombinant gene coding for a protein having an endochitinase activity |
| 01/25/1992 | WO1992001790A1 Endogenously sweetened transgenic plant products |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | WO1992001389A1 Enzymatic treatment of silage |
| 01/25/1992 | CA2066749A1 Analogs of hirudin |
| 01/25/1992 | CA2066734A1 Enzymatic treatment of silage |
| 01/25/1992 | CA2047613A1 Cellulase, method for producing the same and use thereof |
| 01/25/1992 | CA2047585A1 Herpesvirus-based viral vector which expresses a foot and mouth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles, and vaccine against foot and mouth disease containing the same |
| 01/24/1992 | WO1992001795A1 Gamma-carboxylase and methods of use |
| 01/24/1992 | CA2087970A1 Gamma-carboxylase and methods of use |
| 01/23/1992 | WO1992001070A1 High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| 01/23/1992 | WO1992001066A1 Genomic mapping method by direct haplotyping using intron sequence analysis |
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001057A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | WO1992001056A1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 01/23/1992 | WO1992001054A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 01/23/1992 | WO1992001052A1 Dna coding for human fk506-binding protein and expression thereof |
| 01/23/1992 | WO1992001050A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | WO1992001049A2 Cd53 cell surface antigen and use thereof |
| 01/23/1992 | WO1992001048A1 Production of aprotinin in methylotrophic yeast cells |
| 01/23/1992 | WO1992001047A1 Methods for producing members of specific binding pairs |
| 01/23/1992 | WO1992001046A1 Laccase production by recombinant organisms |
| 01/23/1992 | WO1992001045A1 Equine herpesvirus-4 tk- vaccine |
| 01/23/1992 | WO1992001042A1 Transgenic plants expressing industrial enzymes |
| 01/23/1992 | WO1992001040A1 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor |
| 01/23/1992 | WO1992001000A1 Basophil granule proteins |
| 01/23/1992 | WO1992000999A1 Fibroblast growth factor receptors |
| 01/23/1992 | WO1992000993A1 Isolation and purification of lung surfactant protein |
| 01/23/1992 | WO1992000990A1 Interleukin receptor expression inhibiting antisense oligonucleotides |
| 01/23/1992 | WO1992000987A1 Primate lentivirus vaccines |
| 01/23/1992 | WO1992000986A1 Nucleic acid sequences encoding a human dopamine d1 receptor |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | WO1991019793A3 Hybrid plasminogen activators |
| 01/23/1992 | WO1991014770A3 η-CGTase |
| 01/23/1992 | CA2087019A1 Nucleic acid sequences encoding a human dopamine d1 receptor |
| 01/23/1992 | CA2087008A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | CA2086932A1 Basophil granule proteins |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2086740A1 Equine herpesvirus-4 tk-vaccine |
| 01/23/1992 | CA2086739A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | CA2086330A1 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor |
| 01/22/1992 | EP0467839A1 In vitro processing of fusion proteins |
| 01/22/1992 | EP0467782A1 Myocardial infarction immunoassay |
| 01/22/1992 | EP0467676A2 Temperature-inducible secretion expression vectors and their use in prokaryotic cells |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0467366A2 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/22/1992 | EP0467349A1 Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
| 01/22/1992 | EP0467049A1 DNA sequences and amino acid sequences of class b beta-lactamase enzymes from bacteroides fragilis |
| 01/22/1992 | EP0466995A2 Sucrose phosphate synthase (SPS), its process for preparation, its cDNA, and utilization of cDNA to modify the expression of SPS in the plant cells |
| 01/22/1992 | EP0466912A1 Glutathione-s-transferase sm26 of s. mansoni |
| 01/22/1992 | EP0466901A1 Dna segments and transformed microorganisms comprising the gene of delta-1 -dehydrogenase, and uses thereof. |
| 01/22/1992 | EP0466854A1 T cell growth factor |
| 01/22/1992 | EP0466817A1 Recombinant trichosanthin and coding sequence |
| 01/22/1992 | EP0466816A1 Method for enhancing transmembrane transport of exogenous molecules |
| 01/22/1992 | EP0466815A1 Infectious targetted replication-defective virion |
| 01/22/1992 | EP0466811A1 Brassica linkage map |
| 01/22/1992 | EP0466806A1 Phosphatidylinositol linking of proteins |
| 01/22/1992 | EP0466780A1 Megakaryocyte growth promoting activity |
| 01/22/1992 | EP0418320A4 Sequencing dna; a modification of the polymerase chain reaction |
| 01/22/1992 | EP0365591A4 Dietary and hormonal regulation of expression of exogenous genes in transgenic animals under control of the promoter of the gene for phosphoenolpyruvate carboxykinase |
| 01/22/1992 | CN1058045A Cephalosporin acetylhydrolase gene and protein encoded by said gene |
| 01/22/1992 | CN1058044A Method of preparing plasmid having both expressing ability of retrovial gene and processing ability after translation, and resultant plasmid and expression products thereof |
| 01/22/1992 | CN1058043A Gene transfer equipment with electric stimulation |
| 01/21/1992 | WO1992001799A1 Binary cryptocytotoxic method of hybrid seed production |
| 01/21/1992 | US5082830 End labeled nucleotide probe |
| 01/21/1992 | US5082785 From sorbose, genetic engineering |
| 01/21/1992 | US5082784 Cloned kpni restriction-modification system |
| 01/21/1992 | US5082783 Genetic engineering, biosynthesis |
| 01/21/1992 | US5082781 Genetic engineering, biosynthesis, thermostable |
| 01/21/1992 | US5082780 Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures |
| 01/21/1992 | US5082779 Method of directing transgenic expression in animals using a prolactin promoter |
| 01/21/1992 | US5082778 Production of guar alpha-galactosidase by hosts transformed with recombinant dna. methods |
| 01/21/1992 | US5082776 Method of producing an adult t cell leukemia virus fused antigen polypeptide |
| 01/21/1992 | US5082774 Genetic engineering |
| 01/21/1992 | US5082773 Biosynthesis |
| 01/21/1992 | US5082772 Process for preparing deacetylcephalosporin c |
| 01/21/1992 | US5082670 Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
| 01/21/1992 | CA2047000A1 Astaxanthin-generating yeast cells |
| 01/21/1992 | CA1294691C Method and apparatus for obtaining microgravity conditions, particularly in theterrestial gravitational field |
| 01/21/1992 | CA1294570C Monoclonal antibodies specifically directed against prosomal proteins |
| 01/20/1992 | WO1992001715A1 Soluble cell-surface dimeric proteins |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | WO1992001464A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | WO1992001370A1 Biologically safe plant transformation system |
| 01/20/1992 | CA2087545A1 Soluble cell-surface dimeric proteins |